UNIVERSITY OF MIAMI
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1925-01-01
- Employees
- 10K
- Market Cap
- -
A Randomized Clinical Study Comparing Two Closure Techniques of Excised Keloids
- Conditions
- Keloid
- Interventions
- Device: ClozexProcedure: Suture
- First Posted Date
- 2007-08-22
- Last Posted Date
- 2019-03-08
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 3
- Registration Number
- NCT00519493
- Locations
- 🇺🇸
Skin Research Group Office, Miami, Florida, United States
Combination Chemotherapy and Denileukin Diftitox in Treating Patients With Newly Diagnosed T-Cell Non-Hodgkin Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2007-08-08
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- University of Miami
- Registration Number
- NCT00513188
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States
Abraxane, Avastin, and Gemcitabine as First-Line Therapy for Patients With Metastatic Breast Cancer
- First Posted Date
- 2007-07-19
- Last Posted Date
- 2017-05-12
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 30
- Registration Number
- NCT00503906
- Locations
- 🇺🇸
University of Miami, Miami, Florida, United States
Vaccine Therapy in Treating Patients With Stage III, Stage IV, or Relapsed Non-Small Cell Lung Cancer Treated With First-Line Chemotherapy
- Conditions
- Lung Cancer
- Interventions
- Biological: Ad100-gp96Ig-HLA A1
- First Posted Date
- 2007-07-19
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 19
- Registration Number
- NCT00503568
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients
- Conditions
- Prostate CancerPain
- Interventions
- Genetic: GADD45α methylation and expression analysis
- First Posted Date
- 2007-07-19
- Last Posted Date
- 2016-06-09
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 22
- Registration Number
- NCT00503984
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Bortezomib, Arsenic Trioxide, and Melphalan in Treating Patients Undergoing an Autologous Stem Cell Transplant For Multiple Myeloma
- Conditions
- Multiple Myeloma and Plasma Cell Neoplasm
- First Posted Date
- 2007-07-19
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- University of Miami
- Registration Number
- NCT00504101
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States
NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2007-07-11
- Last Posted Date
- 2018-01-02
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 41
- Registration Number
- NCT00499122
- Locations
- 🇺🇸
Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States
🇺🇸University of Miami, Miami, Florida, United States
Study of the Effects of the Pulsed-dye Laser at 585nm and 595nm to Treat Post-operative Scars on Suture-removal Day
- Conditions
- ScarsCicatrix
- Interventions
- Procedure: PDL 1.5 millisecondsProcedure: PDL 450 microseconds
- First Posted Date
- 2007-06-04
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 20
- Registration Number
- NCT00482144
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
- Conditions
- Cervical Cancer
- First Posted Date
- 2007-03-28
- Last Posted Date
- 2016-12-15
- Lead Sponsor
- University of Miami
- Registration Number
- NCT00452920
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center, Miami, Florida, United States
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
- Conditions
- Marginal Zone Lymphoma
- Interventions
- First Posted Date
- 2007-03-28
- Last Posted Date
- 2016-01-01
- Lead Sponsor
- University of Miami
- Target Recruit Count
- 18
- Registration Number
- NCT00453102
- Locations
- 🇺🇸
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami, Florida, United States